IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 68 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2013 | $46,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,200,700 | $13,059,000 | 1.26% |
| Cormorant Asset Management, LP | 400,000 | $1,632,000 | 0.38% |
| NATIXIS | 3,149,116 | $12,849,000 | 0.17% |
| WALL STREET ASSOCIATES | 500,000 | $2,040,000 | 0.17% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 371,759 | $1,517,000 | 0.14% |
| CARL DOMINO INC | 45,137 | $184,000 | 0.10% |
| HOLLENCREST CAPITAL MANAGEMENT | 142,000 | $580,000 | 0.09% |
| Baker Brothers Advisors | 1,613,076 | $6,581,000 | 0.08% |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 81,271 | $332,000 | 0.06% |
| MARSHALL WACE, LLP | 572,305 | $2,335,000 | 0.04% |